Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Radium-223 behandling af knoglemetastaser ved kastrationsrefraktær prostatacancer
Translated title of the contribution
:
Radium-223 treatment of bone metastases from castration-resistant prostate cancer.
Jann Mortensen
,
Liselotte Højgaard
Department of Clinical Medicine
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Radium-223 treatment of bone metastases from castration-resistant prostate cancer.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Castration Resistant Prostate Cancer
100%
Bone Metastasis
100%
Pirenzepine
100%
Alkaline Phosphatase
50%
Adverse Event
50%
Radioisotope
50%
Medicine and Dentistry
Castration Resistant Prostate Cancer
100%
Bone Metastasis
100%
Alkaline Phosphatase
50%
Radioisotope
50%
Adverse Event
50%
Keyphrases
Radium-223
100%
Alkaline Phosphatase Level
50%
Bone Seeking Radionuclides
50%
PSA Level
50%